AbCellera Biologics Inc (NASDAQ: ABCL) is -19.45% lower on its value in year-to-date trading and has touched a low of $2.31 and a high of $5.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.59 in the last trading session, with the day’s loss setting it -0.23%.
Currently trading at $2.36, the stock is -22.88% and -22.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.72 million and changing -8.70% at the moment leaves the stock -20.27% off its SMA200. ABCL registered -53.54% loss for a year compared to 6-month gain of -7.81%.
The stock witnessed a -26.93% loss in the last 1 month and extending the period to 3 months gives it a -16.61%, and is -21.07% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.05% over the week and 7.27% over the month.
AbCellera Biologics Inc (ABCL) has around 586 employees, a market worth around $703.25M and $32.96M in sales. Profit margin for the company is -533.32%. Distance from 52-week low is 2.16% and -55.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-15.36%).
The EPS is expected to shrink by -6.83% this year.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
The shares outstanding are 295.16M, and float is at 223.90M with Short Float at 8.98%.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
A total of 0 insider transactions have happened at AbCellera Biologics Inc (ABCL) in the last six months, with sales accounting for 0 and purchases happening 0 times.
AbCellera Biologics Inc (ABCL): Who are the competitors?
The company’s main competitors (and peers) include AbbVie Inc. (ABBV) that is trading 19.45% up over the past 12 months. Genmab A/S ADR (GMAB) that is -19.47% lower over the same period.
